Agentic AI for Commercial Pharma

AI Agents for Proactive Pharma Commercial Analytics

Your Brand Analytics team is fielding ad-hoc requests from the field while NRx trends shift beneath the surface. The data exists — IQVIA Subnational, Veeva CRM, MMIT formulary feeds. The bottleneck isn't data. It's the two weeks of manual work between "something changed" and "here's why."

Tellius deploys AI agents that work on your pharma data around the clock — investigating NRx drops, diagnosing formulary shifts, and surfacing territory-level root causes before your competitors see them.

Schedule a Demo

See what Tellius can do 30 minutes.

Trusted by the world’s most innovative teams

Ask Tellius

Ask a question, build a workflow, or create an app — in natural language.

Try one of these

Insight NRx for Brand X dropped 12% in the Southeast last 4 weeks — what's driving it? Decompose by territory, payer, HCP decile, and competing brand switches.

Workflow Every Monday: pull NRx by territory from IQVIA Subnational, flag drops over 10% vs. prior 4-week avg, run root cause across payer and HCP dimensions, generate field briefings, push to RBDs via email.

Work Product Generate a Monthly Business Review deck for the Northeast region: NRx trends by brand, market share vs. competitors, top territory movers, formulary change impact, and recommended field actions.

App Build an app that lets RBDs compare their region's NRx share vs. national average, filter by product, payer mix, and HCP decile, and drill into underperforming territories.

Want to try this on your own data?

Connect your warehouse and start investigating in minutes.

Schedule a Demo →

Measurable Impact

Built for Pharma Commercial Speed

340+

Pharma metrics pre-configured

< 60s

Avg. root cause investigation time

88%

Reduction in ad-hoc analyst requests

12×

Faster territory briefings to the field

Commercial Use Cases

From NRx Drops to Formulary Shifts — Investigated in Seconds

Tellius arrives with built-in understanding of prescription metrics, HCP targeting, patient adherence, and territory alignment.

NRx Drop Investigation

Automatically detect and diagnose NRx declines across territories, HCP deciles, payer segments, and competing brand switches — before the field notices.

847 dimensions analyzed in < 60s

Formulary & Access Monitoring

Track formulary status changes, prior authorization spikes, and step therapy edits across PBMs. Surface access barriers before they impact NRx trajectory.

Proactive PA spike alerts

HCP Targeting & SFE

Identify high-potential HCPs by decile, call plan attainment gaps, and territory alignment issues. Optimize reach and frequency for maximum NRx impact.

Auto-ranked by Shapley attribution

Market Share & Competitive Intel

Decompose TRx share movement into brand switching, new patient starts, and adherence shifts. Know exactly where competitors are gaining — and why.

Brand-vs-generic switching tracked

Automated Field Briefings

Generate weekly territory briefings with NRx trends, root causes, and recommended actions — pushed directly to RBDs and DMs every Monday morning.

Monday-ready, zero analyst time

Patient Adherence & Switching

Track PDC trends, therapy discontinuation patterns, and brand-to-generic switching at the territory level using APLD longitudinal data.

Patient-level journey analysis

Always-On Intelligence

Pharma-Native AI Agents

Agents that understand NRx vs TRx, formulary dynamics, HCP deciles, and territory alignment — out of the box.

Active

NRx Drop Investigator

Monitors NRx across all territories. When drops exceed threshold, automatically decomposes root cause across 847 dimensions and generates field briefings.

NRx / TRx Root Cause Weekly

Active

Formulary Change Monitor

Tracks formulary status changes, PA requirement shifts, and step therapy edits across all major PBMs. Alerts brand teams before impact hits prescribing.

MMIT PA / ST Real-time

Monitoring

Competitive Share Tracker

Continuous TRx share monitoring vs. key competitors. Detects share shifts by geography, payer, and HCP segment with automated competitive briefings.

Market Share Brand Switch

Active

Territory Performance Agent

Ranks territories by NRx performance, call plan attainment, and HCP reach. Identifies underperformers and recommends field action priorities.

SFE Territory Weekly

Learning

Patient Journey Analyst

Analyzes APLD data to track patient adherence (PDC), therapy switching patterns, and time-to-abandonment by geography and payer segment.

APLD PDC Adherence

Active

MBR Deck Generator

Automatically generates Monthly Business Review decks with NRx trends, market share, territory rankings, access changes, and recommended actions.

Work Product Monthly

Ready to Put Your Pharma Data to Work?

Connect IQVIA Subnational, Veeva CRM, or your cloud warehouse. Start investigating NRx trends in minutes — not weeks.

Schedule a Demo →

DISCOVER MORE

Breakthrough Ideas, Right at Your Fingertips

Dig into our latest guides, webinars, whitepapers, and best practices that help you leverage data for tangible, scalable results.

Start with the Mission

This blog argues that successful analytics and AI initiatives don’t start with tools or dashboards—they start with a clear mission tied to real business outcomes. It highlights how organizations often get stuck in cycles of data exploration without direction, leading to wasted time and low impact. Instead, leaders should define the decisions they want to improve, align analytics efforts to those goals, and build workflows that move from insight to action. By grounding analytics in mission-driven use cases, companies can reduce manual effort, accelerate decision-making, and unlock the full value of AI-powered insights.

Best AI Platforms for Pharma Commercial Analytics in 2026: 11 Platforms Compared

This guide compares the 11 best AI platforms for pharma commercial analytics in 2026, evaluating how each supports brand performance, market access, patient analytics, field force effectiveness, incentive compensation, and omnichannel engagement. It highlights a key shift in the market: traditional BI and SFE tools focus on reporting what happened, while newer AI platforms differentiate by investigating why performance changed. The post breaks down core capabilities like root cause analysis, data integration, governance, and agentic workflows—helping pharma teams identify which platforms can deliver faster, more actionable insights across commercial operations.

Your Data Is In The Warehouse. The Model That Makes It Useful Isn’t. Introducing Kaiya Architect.

Tellius introduces Kaiya Architect, an AI data modeling agent that builds governed semantic layers from raw warehouse data through a single conversation — eliminating the multi-week engineering bottleneck between business need and analysis.

Tellius 6.1: AI Agents Across Every Metric, Document, and Conversation

Tellius 6.0: Agent Mode for Deep Analytics + Insights

AI Agents: The fastest way to put GenAI to work

Tellius AI Agents: Driving Real Analysis, Action, + Enterprise Intelligence

Tellius AI Agents transform business intelligence with dedicated AI squads that automate complex analysis workflows without coding. Join our April 17th webinar to discover how these agents can 100x enterprise productivity by turning questions into actionable insights, adapting to your unique business processes, and driving decisions with trustworthy, explainable intelligence.

PMSA Fall Symposium 2025 in Boston

Join Tellius at PMSA Oct 2–3 for two can’t-miss sessions: Regeneron on how they’re scaling GenAI across the pharma brand lifecycle, and a hands-on workshop on AI Agents for sales, HCP targeting, and access wins. Discover how AI-powered analytics drives commercial success.

View All Resources